We are live on ! Find out more
EBACW

European Biotech Acquisition Corp. Warrant
EBACW

Delisted

EBACW was delisted on the 2nd of March, 2023.

Back to rankings

26 hedge funds and large institutions have $1.75M invested in European Biotech Acquisition Corp. Warrant in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more funds holding

Funds holding: 21 → 26 (+5)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

15% less capital invested

Capital invested by funds: $2.06M → $1.75M (-$313K)

Holders
26
Holders Change
+5
Holders Change %
+23.81%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
3
Closed
–
Calls
$1.07M
Puts
–
Net Calls
+$1.07M
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
ACA
Arena Capital Advisors
California
+$58.6K
2
Citadel Advisors
Citadel Advisors
Florida
+$32.6K
3
CCM
CAAS Capital Management
New York
+$25.9K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$20.3K
5
GF
Gabelli Funds
New York
+$19K

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$78.4K
2
AC
Athanor Capital
New York
-$5.81K
3
MI
MMCAP International
Cayman Islands
-$4.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$649K – – –
AC
2
Athanor Capital
New York
$380K -$5.81K -7,465 -16%
Citadel Advisors
3
Citadel Advisors
Florida
$173K +$32.6K +41,951 +16%
SCM
4
Suvretta Capital Management
New York
$62K – – –
ACA
5
Arena Capital Advisors
California
$62K +$58.6K +75,299 +301%
WP
6
Woodline Partners
California
$52K – – –
MI
7
MMCAP International
Cayman Islands
$48K -$4.6K -5,908 -7%
SC
8
Sculptor Capital
New York
$41K – – –
LA
9
Linden Advisors
New York
$39K -$78.4K -100,693 -61%
FTCM
10
Fir Tree Capital Management
New York
$29K – – –
PMAM
11
Picton Mahoney Asset Management
Ontario, Canada
$25K – – –
MCM
12
Moore Capital Management
New York
$24K – – –
TCM
13
Tenor Capital Management
New York
$21K – – –
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$21K +$20.3K +26,105 +235%
CCM
15
CAAS Capital Management
New York
$21K +$25.9K +33,333 New
DCM
16
Dupont Capital Management
Delaware
$19K – – –
GF
17
Gabelli Funds
New York
$15K +$19K +24,434 New
GCIA
18
Gabelli & Co Investment Advisers
New York
$14K +$17K +21,896 New
SCC
19
Spring Creek Capital
Kansas
$10K – – –
AA
20
AQR Arbitrage
Connecticut
$9K – – –
EAM
21
Exos Asset Management
New York
$9K – – –
ACM
22
Atalaya Capital Management
New York
$8K – – –
VI
23
Vestcor Inc
New Brunswick, Canada
$7K – – –
OAC
24
OMERS Administration Corp
Ontario, Canada
$7K +$9.08K +11,666 New
AA
25
Ancora Advisors
Ohio
$1K – – –
1
2

EBACW Hedge Fund Activity: Q3 2021 in Review

26 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Warrant (EBACW) for Q3 2021, worth a combined $1.75M — down 15% from $2.06M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new EBACW positions and 0 closed out — a net gain of 5 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Arena Capital Advisors, adding an estimated $58.6K. The largest seller was Linden Advisors, cutting an estimated $78.4K.

  • 26 institutional investors held European Biotech Acquisition Corp. Warrant (EBACW) as of Q3 2021, up from 21 in Q2 2021.
  • Funds reported $1.75M of European Biotech Acquisition Corp. Warrant stock for Q3 2021, down 15% quarter-over-quarter.
  • 5 funds opened new European Biotech Acquisition Corp. Warrant positions in Q3 2021 and 0 closed out, a net change of +5 holders.
  • The largest European Biotech Acquisition Corp. Warrant buyer in Q3 2021 was Arena Capital Advisors, an estimated $58.6K added.
  • The largest European Biotech Acquisition Corp. Warrant seller in Q3 2021 was Linden Advisors, an estimated $78.4K sold.

Based on aggregated 13F filings for Q3 2021.